Publications by authors named "Felicitas Schulz"

Claim this Profile
D
Dynamic Mortality Risk Prediction in Myelodysplastic Syndromes Using Longitudinal Clinical Data.
Jonathan Bobak, Philipp Spohr, Sarah Richter, Alexander Streuer, Felicitas Isabel Schulz

JCO Clin Cancer Inform· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early CMV DNAemia during letermovir prophylaxis predicts lower risk of late CMV infection and is associated with enhanced T-cell immunity after alloHSCT.
Timothé Duplessix, Ben-Niklas Baermann, Alexander Sebastian Hölscher, Inga Tometten, Felicitas Schulz

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of prognostication by IPSS-M, IPSS-R and AIPSS-MDS in the context of limited availability of molecular data in daily clinical practice.
Felicitas Schulz, Carolin Kellersmann, Beate Betz, Barbara Hildebrandt, Annika Kasprzak

Ann Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-curative therapies and their impact on the prognosis of patients with myelodysplastic syndromes- a retrospective matched-pairs analysis.
Katharina Anna Rauhe, Annika Kasprzak, Felicitas Schulz, Kathrin Nachtkamp, Corinna Strupp

Ann Hematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haploidentical Allogeneic Stem Cell Transplantation as a Superior Alternative for Patients With Mismatch Donors-A Single Center Experience in 152 Patients.
Paul Jäger, Benno Biermann, Nora Liebers, Felicitas Schulz, Ben-Niklas Baermann

EJHaem· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular.
Sandra Castaño-Díez, Mònica López-Guerra, Inés Zugasti, Xavier Calvo, Felicitas Isabel Schulz

Blood Adv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in patients with acute myeloid leukemia older than 70 years within the last 30 years, a single center experience.
Felicitas Schulz, Claudia Roggenbuck, Andrea Kündgen, Annika Kasprzak, Kathrin Nachtkamp

Ann Hematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common variants increase risk for congenital diaphragmatic hernia within the context of de novo variants.
Lu Qiao, Carrie L Welch, Rebecca Hernan, Julia Wynn, Usha S Krishnan, Felicitas Schulz

Am J Hum Genet· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion.
Maria Julia Montoro, Laura Palomo, Claudia Haferlach, Pamela Acha, Onyee Chan, Felicitas Isabel Schulz

Blood· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic myelomonocytic leukemia with ring sideroblasts/ mutation presents with low monocyte count and resembles myelodysplastic syndromes with-RS/ mutation in terms of phenotype and prognosis.
Blanca Xicoy, Helena Pomares, Mireia Morgades, Ulrich Germing, Montserrat Arnan, Felicitas Schulz

Front Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a novel algorithm with a high specificity in ruling out MDS.
Felicitas Schulz, Kathrin Nachtkamp, Howard S Oster, Moshe Mittelman, Norbert Gattermann

Int J Lab Hematol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infectious Complications in Patients with Myelodysplastic Syndromes: A Report from the Düsseldorf MDS Registry.
Annika Kasprzak, Julia Andresen, Kathrin Nachtkamp, Andrea Kündgen, Felicitas Schulz

Cancers (Basel)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies.
Felicitas Schulz, Paul Jäger, Johanna Tischer, Alessia Fraccaroli, Gesine Bug

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and clinical aspects relevant for counseling individuals with clonal hematopoiesis of indeterminate potential.
Anna Maria Cacic, Felicitas Isabel Schulz, Ulrich Germing, Sascha Dietrich, Norbert Gattermann

Front Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron Chelation in Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms-Real-World Data from the German Noninterventional Study EXCALIBUR.
Felicitas Schulz, Ulrich Hauch, Sandra Ketzler-Henkel, Eyck von der Heyde, Michael Koenigsmann

J Clin Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parental risk factors for congenital diaphragmatic hernia - a large German case-control study.
Felicitas Schulz, Ekkehart Jenetzky, Nadine Zwink, Charlotte Bendixen, Florian Kipfmueller

BMC Pediatr· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Luspatercept as a therapy for myelodysplastic syndromes with ring sideroblasts.
Felicitas Schulz, Kathrin Nachtkamp, Annika Kasprzak, Norbert Gattermann, Rainer Haas

Expert Rev Hematol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis